doi:10.1371/journal.pone.0033944 Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ et al (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
Understanding the structure and function of ZIP transporters may offer valuable insights for developing new therapeutic strategies targeting zinc transporters to treat various human diseases
2016;11:e0152749
Are there any side effects to B12 IV therapy
This cutting-edge medical procedure is designed to optimize your bodys performance, reduce systemic inflammation, slow the aging process, and support overall vitality